The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

COVID-19 is known primarily as a respiratory disease, with symptoms that include cough, shortness of breath, and, in severe cases, acute respiratory distress syndrome and pneumonia. Now, researchers ...

Guanosine, a purine nucleoside, has emerged as a potent modulator within the central nervous system (CNS), contributing to neuroprotection through a diverse array of mechanisms. It plays a critical ...

The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...

LONDON--(BUSINESS WIRE)--According to the latest report published by Technavio, the central nervous system disorders therapeutics market size is poised to grow by USD 23.16 billion during 2020-2024, ...

Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday ...

Detailed price information for Aldeyra Therapeu (ALDX-Q) from The Globe and Mail including charting and trades.

Technavio has been monitoring the Center Nervous System Disorder Therapeutics Market and the market size is expected to reach a value of USD 24.35 billion at a CAGR of 4.44% during 2021-2025. This ...

NEW YORK, July 12, 2024 /PRNewswire/ -- The global central nervous system (CNS) stimulant drugs market size is estimated to grow by USD 6.48 billion from 2023-2027, according to Technavio. The market ...